{"product_id":"polopyrine-s-300mg-x-30","title":"Polopyrine S (Polopiryna) 300mg x 30","description":"\u003ch1\u003e\u003cspan\u003e\u003cspan style=\"text-decoration: underline;\"\u003e\u003cem\u003e\u003cstrong\u003ePolopyrine S (Polopiryna) 300mg x 30 tablets\u003c\/strong\u003e\u003c\/em\u003e\u003c\/span\u003e\u003c\/span\u003e\u003c\/h1\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003e\u003cspan style=\"text-decoration: underline;\"\u003e\u003cem\u003e\u003cstrong\u003ePolopyrine S (Polopiryna)\u003c\/strong\u003e\u003c\/em\u003e\u003c\/span\u003e 300mg contains acetylsalicylic acid.\u003cspan\u003e \u003c\/span\u003e\u003c\/span\u003e\u003cspan\u003eIt is an active substance with analgesic, antipyretic and anti-inflammatory effect.\u003cspan\u003e \u003c\/span\u003e\u003c\/span\u003e\u003cspan\u003eThe drug is indicated for adults and adolescents over 16 years of age.\u003c\/span\u003e\u003c\/p\u003e\n\u003ch2\u003e\u003cspan\u003eComposition Polopyrine S (Polopiryna) 300mg:\u003c\/span\u003e\u003c\/h2\u003e\n\u003cp\u003e\u003cspan\u003eActive substance: acetylsalicylic acid.\u003cspan\u003e \u003c\/span\u003eOne tablet contains 300mg of acetylsalicylic acid and excipients: corn starch, powdered cellulose, microcrystalline cellulose.\u003c\/span\u003e\u003c\/p\u003e\n\u003ch3\u003e\u003cspan\u003eAction Polopyrine S (Polopiryna) 300mg:\u003c\/span\u003e\u003c\/h3\u003e\n\u003cp\u003e\u003cspan\u003eThe active substance used in the medicinal product Polopiryna S 300mg is acetylsalicylic acid.\u003cspan\u003e \u003c\/span\u003eIt is an anti-inflammatory, analgesic and antipyretic drug.\u003cspan\u003e \u003c\/span\u003eIndications for use of the drug are, among others\u003cspan\u003e \u003c\/span\u003emild to moderate pain, symptoms of colds and flu with fever, as well as rheumatoid arthritis.\u003c\/span\u003e\u003c\/p\u003e\n\u003ch3\u003e\u003cspan\u003eApplication of Polopyrine S (Polopiryna) 300mg:\u003c\/span\u003e\u003c\/h3\u003e\n\u003cp\u003e\u003cspan\u003eThe medicinal product Polopirin S 300mg indicated for use in the treatment of: pain of various origins of mild or moderate severity (including headache, toothache, muscle pain, joint pain);\u003cspan\u003e \u003c\/span\u003eailments that accompany colds and flu with fever;\u003cspan\u003e \u003c\/span\u003emedical conditions that require long-term use of high-dose acetylsalicylic acid, including rheumatoid arthritis, and in the treatment of myocardial infarction and prophylaxis of recurrent myocardial infarction.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003eAdditional information: \u003c\/span\u003e\u003c\/strong\u003eThe \u003cspan\u003eproduct should be stored out of reach of children at room temperature.\u003cspan\u003e \u003c\/span\u003eIt is recommended to protect against moisture and light.\u003cspan\u003e \u003c\/span\u003eThe possibility of using the drug in the first and second trimester of pregnancy should be consulted with a doctor.\u003cspan\u003e \u003c\/span\u003eDo not drink alcohol during treatment.\u003c\/span\u003e\u003c\/p\u003e\n\u003ch3\u003e\u003cspan\u003eContraindications Polopyrine S (Polopiryna) 300mg:\u003c\/span\u003e\u003c\/h3\u003e\n\u003cp\u003e\u003cspan\u003eDo not use in case of hypersensitivity to any component of the drug, as well as to other nonsteroidal anti-inflammatory drugs.\u003cspan\u003e \u003c\/span\u003eDo not use in the case of bronchial asthma, chronic respiratory disease, hay fever or swelling of the nasal mucosa.\u003cspan\u003e \u003c\/span\u003eDo not use in the case of active gastric and \/ or duodenal ulcer, inflammation or gastrointestinal bleeding (gastrointestinal bleeding or ulceration may occur), severe liver or kidney failure, severe heart failure;\u003cspan\u003e \u003c\/span\u003eblood coagulation disorders (e.g. haemophilia, thrombocytopenia).\u003cspan\u003e \u003c\/span\u003eDo not use simultaneously with anticoagulants (e.g. coumarin derivatives, heparin).\u003cspan\u003e \u003c\/span\u003eDo not use in the case of glucose-6-phosphate dehydrogenase deficiency.\u003cspan\u003e \u003c\/span\u003eDo not use concomitantly with methotrexate at doses of 15mg weekly or higher.\u003cspan\u003e \u003c\/span\u003eDo not use in children and adolescents under 16 years of age (primarily in the course of viral infections, due to the risk of Reye's syndrome).\u003cspan\u003e \u003c\/span\u003eDo not use during the third trimester of pregnancy and during breast-feeding.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003eSide effects:\u003c\/span\u003e\u003c\/strong\u003e\u003cbr\u003e\u003cspan\u003eSome people may experience side effects when taking this medicine.\u003cspan\u003e \u003c\/span\u003eSide effects after using acetylsalicylic acid.\u003cspan\u003e \u003c\/span\u003eBlood and lymphatic system disorders: thrombocytopenia, gastrointestinal micro-bleeding anemia, hemolytic anemia in patients with glucose-6-phosphate dehydrogenase deficiency, leukopenia, agranulocytosis, eosinopenia, increased risk of bleeding, prolonged bleeding time, prolonged prothrombin time.\u003cspan\u003e \u003c\/span\u003eImmune system disorders: hypersensitivity reactions: rash, urticaria, angioedema, bronchospasm, shock.\u003cspan\u003e \u003c\/span\u003eNervous system disorders: tinnitus (usually a sign of overdose), hearing impairment, dizziness.\u003cspan\u003e \u003c\/span\u003eCardiac disorders: heart failure.\u003cspan\u003e \u003c\/span\u003eVascular disorders: hypertension.\u003cspan\u003e \u003c\/span\u003eGastrointestinal disorders: indigestion, heartburn\u003cspan\u003e \u003c\/span\u003eepigastric fullness, nausea, vomiting, anorexia, abdominal pain, gastrointestinal bleeding, gastric mucosal damage, ulcer disease, perforation (gastric ulcer occurs in 15% of patients receiving acetylsalicylic acid for long periods).\u003cspan\u003e \u003c\/span\u003eHepato-biliary disorders: focal hepatocellular necrosis, tenderness and enlargement of the liver (especially in patients with juvenile rheumatoid arthritis, systemic lupus erythematosus, rheumatic fever or liver disease), transient increases in serum transaminases, alkaline phosphatase and bilirubin .\u003cspan\u003e \u003c\/span\u003eRenal and urinary disorders: proteinuria, presence of leukocytes and erythrocytes in urine, renal papillary necrosis, interstitial nephritis.\u003cspan\u003e \u003c\/span\u003eanorexia, abdominal pain, gastrointestinal bleeding, damage to the gastric mucosa, ulceration, perforation (gastric ulcer occurs in 15% of patients on chronic acetylsalicylic acid treatment).\u003cspan\u003e \u003c\/span\u003eHepato-biliary disorders: focal hepatocellular necrosis, tenderness and enlargement of the liver (especially in patients with juvenile rheumatoid arthritis, systemic lupus erythematosus, rheumatic fever or liver disease), transient increases in serum transaminases, alkaline phosphatase and bilirubin .\u003cspan\u003e \u003c\/span\u003eRenal and urinary disorders: proteinuria, presence of leukocytes and erythrocytes in urine, renal papillary necrosis, interstitial nephritis.\u003cspan\u003e \u003c\/span\u003eanorexia, abdominal pain, gastrointestinal bleeding, damage to the gastric mucosa, ulceration, perforation (gastric ulcer occurs in 15% of patients on chronic acetylsalicylic acid treatment).\u003cspan\u003e \u003c\/span\u003eHepato-biliary disorders: focal hepatocellular necrosis, tenderness and enlargement of the liver (especially in patients with juvenile rheumatoid arthritis, systemic lupus erythematosus, rheumatic fever or liver disease), transient increases in serum transaminases, alkaline phosphatase and bilirubin .\u003cspan\u003e \u003c\/span\u003eRenal and urinary disorders: proteinuria, presence of leukocytes and erythrocytes in urine, renal papillary necrosis, interstitial nephritis.\u003cspan\u003e \u003c\/span\u003eactivating a peptic ulcer, perforation (gastric ulcer occurs in 15% of patients on long-term intake of acetylsalicylic acid).\u003cspan\u003e \u003c\/span\u003eHepato-biliary disorders: focal hepatocellular necrosis, tenderness and enlargement of the liver (especially in patients with juvenile rheumatoid arthritis, systemic lupus erythematosus, rheumatic fever or liver disease), transient increases in serum transaminases, alkaline phosphatase and bilirubin .\u003cspan\u003e \u003c\/span\u003eRenal and urinary disorders: proteinuria, presence of leukocytes and erythrocytes in urine, renal papillary necrosis, interstitial nephritis.\u003cspan\u003e \u003c\/span\u003eactivating a peptic ulcer, perforation (gastric ulcer occurs in 15% of patients on long-term intake of acetylsalicylic acid).\u003cspan\u003e \u003c\/span\u003eHepato-biliary disorders: focal hepatocellular necrosis, tenderness and enlargement of the liver (especially in patients with juvenile rheumatoid arthritis, systemic lupus erythematosus, rheumatic fever or liver disease), transient increases in serum transaminases, alkaline phosphatase and bilirubin .\u003cspan\u003e \u003c\/span\u003eRenal and urinary disorders: proteinuria, presence of leukocytes and erythrocytes in urine, renal papillary necrosis, interstitial nephritis.\u003cspan\u003e \u003c\/span\u003efocal hepatic necrosis, tenderness and enlargement of the liver (especially in patients with juvenile rheumatoid arthritis, systemic lupus erythematosus, rheumatic fever or liver disease), transient increases in serum transaminases, alkaline phosphatase and bilirubin.\u003cspan\u003e \u003c\/span\u003eRenal and urinary disorders: proteinuria, presence of leukocytes and erythrocytes in urine, renal papillary necrosis, interstitial nephritis.\u003cspan\u003e \u003c\/span\u003efocal hepatic necrosis, tenderness and enlargement of the liver (especially in patients with juvenile rheumatoid arthritis, systemic lupus erythematosus, rheumatic fever or liver disease), transient increases in serum transaminases, alkaline phosphatase and bilirubin.\u003cspan\u003e \u003c\/span\u003eRenal and urinary disorders: proteinuria, presence of leukocytes and erythrocytes in urine, renal papillary necrosis, interstitial nephritis.\u003c\/span\u003e\u003c\/p\u003e\n\u003ch2\u003e\u003cspan\u003eDosage of Polopyrine S (Polopiryna) 300mg tablets:\u003c\/span\u003e\u003c\/h2\u003e\n\u003cp\u003e\u003cspan\u003eUse as directed by your doctor or the instructions on the leaflet.\u003cspan\u003e \u003c\/span\u003eUse orally, take during or after a meal, drink plenty of water.\u003cspan\u003e \u003c\/span\u003eIf you have trouble swallowing, you can first dissolve half a glass of water or milk.\u003cspan\u003e \u003c\/span\u003eFor pain and fever usually used - adults: 1-2 tablets (300-600mg acetylsalicylic acid) every 4 hours.\u003cspan\u003e \u003c\/span\u003eMaximum daily dose: 3g acetylsalicylic acid.\u003cspan\u003e \u003c\/span\u003eAdolescents over 16 years of age: 2-3 tablets daily (600-900mg acetylsalicylic acid).\u003cspan\u003e \u003c\/span\u003eIn inflammation, it is recommended to use after consulting a doctor, usually used: in rheumatic fever: 3 tablets (900mg of acetylsalicylic acid) 4 times a day;\u003cspan\u003e \u003c\/span\u003ein rheumatoid arthritis: 2 tablets (600mg acetylsalicylic acid) 3-4 times a day.\u003cspan\u003e \u003c\/span\u003eMyocardial infarction, prevention of myocardial infarction:\u003cspan\u003e \u003c\/span\u003e1 \/ 2-1 tablets (150-300mg acetylsalicylic acid) daily.\u003cspan\u003e \u003c\/span\u003eDuration of symptomatic treatment: without consultation, it can be used for a maximum of 3 days.\u003cspan\u003e \u003c\/span\u003eThe lowest effective doses are recommended.\u003c\/span\u003e\u003c\/p\u003e\n\u003ch2\u003e\u003cspan style=\"text-decoration: underline;\"\u003ePolopyrine S (Polopiryna) 300mg x 30 tablets\u003c\/span\u003e\u003c\/h2\u003e","brand":"Polpharma","offers":[{"title":"Default Title","offer_id":54929866129785,"sku":"36729","price":39.99,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0903\/0792\/0249\/files\/Polopyrine_S_Polopiryna_300mg_x_30_tablets.jpg?v=1769085137","url":"https:\/\/ukdorf.co.uk\/products\/polopyrine-s-300mg-x-30","provider":"UKDorf (ELIVERA) Buy online, Reviews Est. 1988 London, UK.","version":"1.0","type":"link"}